SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY
SUBSTITUTED AND PYRIDINES AND PYRIDAZINES HAVING ANGIOGENESIS INHIBITING ACTIVITY AND THE GENERALIZED STRUCTURAL FORMULA (FORMULA)WHEREIN THE RING CONTAINING A, B, D, E, AND L IS PHENYL OR A NITROGEN-CONTAINING HETEROCYCLE; GROUPS X AND Y MAY BE ANY OF A VARIETY OF DEFINED LINKING UNITS; R1 AND R2 M...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ROBERT N. SIBLEY JULIE A. DIXON STEPHEN JAMES BOYER TEDDY KITE JOE NING SU DANAPALAN NAGARATHNAM HAROLD C.E. KLUENDER JACQUES P. DUMAS WENDY LEE |
| description | SUBSTITUTED AND PYRIDINES AND PYRIDAZINES HAVING ANGIOGENESIS INHIBITING ACTIVITY AND THE GENERALIZED STRUCTURAL FORMULA (FORMULA)WHEREIN THE RING CONTAINING A, B, D, E, AND L IS PHENYL OR A NITROGEN-CONTAINING HETEROCYCLE; GROUPS X AND Y MAY BE ANY OF A VARIETY OF DEFINED LINKING UNITS; R1 AND R2 MAY BE DEFINED INDEPENDENT SUBSTITUENTS OR TOGETHER MAY BE A RING-DEFINING BRIDGE; RING J MAY BE AN ARYL , PYRIDYL, OR CYCLOALKYL GROUP; AND G GROUPS MAY BE ANY OF A VARIETY OF DEFINED SUBSTITUENTS. PHARMACEUTICAL COMPOSITIONS CONTAINING THESE MATERIALS, AND METHODS OF TREATING A MAMMAL HAVING A CONDITION CHARACTERIZED BY ABNORMAL ANGIOGENESIS OR HYPERPERMIABILITY PROCESSES USING THESE MATERIALS ARE ALSO DISCLOSED. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MY143377A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MY143377A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MY143377A3</originalsourceid><addsrcrecordid>eNrjZPAODnUKDvEMCQ1xdVEIiAzydPH0cw1WcPSD8hyjwPxwzxAPoKC7p7-7K5DvGazg6efh6eQZ4unnruDoHOIZ5hkSycPAmpaYU5zKC6W5GeTcXEOcPXRTC_LjU4sLEpNT81JL4n0jDU2Mjc3NHY0JKgAA4TgtTg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY</title><source>esp@cenet</source><creator>ROBERT N. SIBLEY ; JULIE A. DIXON ; STEPHEN JAMES BOYER ; TEDDY KITE JOE ; NING SU ; DANAPALAN NAGARATHNAM ; HAROLD C.E. KLUENDER ; JACQUES P. DUMAS ; WENDY LEE</creator><creatorcontrib>ROBERT N. SIBLEY ; JULIE A. DIXON ; STEPHEN JAMES BOYER ; TEDDY KITE JOE ; NING SU ; DANAPALAN NAGARATHNAM ; HAROLD C.E. KLUENDER ; JACQUES P. DUMAS ; WENDY LEE</creatorcontrib><description>SUBSTITUTED AND PYRIDINES AND PYRIDAZINES HAVING ANGIOGENESIS INHIBITING ACTIVITY AND THE GENERALIZED STRUCTURAL FORMULA (FORMULA)WHEREIN THE RING CONTAINING A, B, D, E, AND L IS PHENYL OR A NITROGEN-CONTAINING HETEROCYCLE; GROUPS X AND Y MAY BE ANY OF A VARIETY OF DEFINED LINKING UNITS; R1 AND R2 MAY BE DEFINED INDEPENDENT SUBSTITUENTS OR TOGETHER MAY BE A RING-DEFINING BRIDGE; RING J MAY BE AN ARYL , PYRIDYL, OR CYCLOALKYL GROUP; AND G GROUPS MAY BE ANY OF A VARIETY OF DEFINED SUBSTITUENTS. PHARMACEUTICAL COMPOSITIONS CONTAINING THESE MATERIALS, AND METHODS OF TREATING A MAMMAL HAVING A CONDITION CHARACTERIZED BY ABNORMAL ANGIOGENESIS OR HYPERPERMIABILITY PROCESSES USING THESE MATERIALS ARE ALSO DISCLOSED.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110513&DB=EPODOC&CC=MY&NR=143377A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110513&DB=EPODOC&CC=MY&NR=143377A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ROBERT N. SIBLEY</creatorcontrib><creatorcontrib>JULIE A. DIXON</creatorcontrib><creatorcontrib>STEPHEN JAMES BOYER</creatorcontrib><creatorcontrib>TEDDY KITE JOE</creatorcontrib><creatorcontrib>NING SU</creatorcontrib><creatorcontrib>DANAPALAN NAGARATHNAM</creatorcontrib><creatorcontrib>HAROLD C.E. KLUENDER</creatorcontrib><creatorcontrib>JACQUES P. DUMAS</creatorcontrib><creatorcontrib>WENDY LEE</creatorcontrib><title>SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY</title><description>SUBSTITUTED AND PYRIDINES AND PYRIDAZINES HAVING ANGIOGENESIS INHIBITING ACTIVITY AND THE GENERALIZED STRUCTURAL FORMULA (FORMULA)WHEREIN THE RING CONTAINING A, B, D, E, AND L IS PHENYL OR A NITROGEN-CONTAINING HETEROCYCLE; GROUPS X AND Y MAY BE ANY OF A VARIETY OF DEFINED LINKING UNITS; R1 AND R2 MAY BE DEFINED INDEPENDENT SUBSTITUENTS OR TOGETHER MAY BE A RING-DEFINING BRIDGE; RING J MAY BE AN ARYL , PYRIDYL, OR CYCLOALKYL GROUP; AND G GROUPS MAY BE ANY OF A VARIETY OF DEFINED SUBSTITUENTS. PHARMACEUTICAL COMPOSITIONS CONTAINING THESE MATERIALS, AND METHODS OF TREATING A MAMMAL HAVING A CONDITION CHARACTERIZED BY ABNORMAL ANGIOGENESIS OR HYPERPERMIABILITY PROCESSES USING THESE MATERIALS ARE ALSO DISCLOSED.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPAODnUKDvEMCQ1xdVEIiAzydPH0cw1WcPSD8hyjwPxwzxAPoKC7p7-7K5DvGazg6efh6eQZ4unnruDoHOIZ5hkSycPAmpaYU5zKC6W5GeTcXEOcPXRTC_LjU4sLEpNT81JL4n0jDU2Mjc3NHY0JKgAA4TgtTg</recordid><startdate>20110513</startdate><enddate>20110513</enddate><creator>ROBERT N. SIBLEY</creator><creator>JULIE A. DIXON</creator><creator>STEPHEN JAMES BOYER</creator><creator>TEDDY KITE JOE</creator><creator>NING SU</creator><creator>DANAPALAN NAGARATHNAM</creator><creator>HAROLD C.E. KLUENDER</creator><creator>JACQUES P. DUMAS</creator><creator>WENDY LEE</creator><scope>EVB</scope></search><sort><creationdate>20110513</creationdate><title>SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY</title><author>ROBERT N. SIBLEY ; JULIE A. DIXON ; STEPHEN JAMES BOYER ; TEDDY KITE JOE ; NING SU ; DANAPALAN NAGARATHNAM ; HAROLD C.E. KLUENDER ; JACQUES P. DUMAS ; WENDY LEE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MY143377A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ROBERT N. SIBLEY</creatorcontrib><creatorcontrib>JULIE A. DIXON</creatorcontrib><creatorcontrib>STEPHEN JAMES BOYER</creatorcontrib><creatorcontrib>TEDDY KITE JOE</creatorcontrib><creatorcontrib>NING SU</creatorcontrib><creatorcontrib>DANAPALAN NAGARATHNAM</creatorcontrib><creatorcontrib>HAROLD C.E. KLUENDER</creatorcontrib><creatorcontrib>JACQUES P. DUMAS</creatorcontrib><creatorcontrib>WENDY LEE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ROBERT N. SIBLEY</au><au>JULIE A. DIXON</au><au>STEPHEN JAMES BOYER</au><au>TEDDY KITE JOE</au><au>NING SU</au><au>DANAPALAN NAGARATHNAM</au><au>HAROLD C.E. KLUENDER</au><au>JACQUES P. DUMAS</au><au>WENDY LEE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY</title><date>2011-05-13</date><risdate>2011</risdate><abstract>SUBSTITUTED AND PYRIDINES AND PYRIDAZINES HAVING ANGIOGENESIS INHIBITING ACTIVITY AND THE GENERALIZED STRUCTURAL FORMULA (FORMULA)WHEREIN THE RING CONTAINING A, B, D, E, AND L IS PHENYL OR A NITROGEN-CONTAINING HETEROCYCLE; GROUPS X AND Y MAY BE ANY OF A VARIETY OF DEFINED LINKING UNITS; R1 AND R2 MAY BE DEFINED INDEPENDENT SUBSTITUENTS OR TOGETHER MAY BE A RING-DEFINING BRIDGE; RING J MAY BE AN ARYL , PYRIDYL, OR CYCLOALKYL GROUP; AND G GROUPS MAY BE ANY OF A VARIETY OF DEFINED SUBSTITUENTS. PHARMACEUTICAL COMPOSITIONS CONTAINING THESE MATERIALS, AND METHODS OF TREATING A MAMMAL HAVING A CONDITION CHARACTERIZED BY ABNORMAL ANGIOGENESIS OR HYPERPERMIABILITY PROCESSES USING THESE MATERIALS ARE ALSO DISCLOSED.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_MY143377A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T06%3A28%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ROBERT%20N.%20SIBLEY&rft.date=2011-05-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMY143377A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |